These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8583727)
1. [Systemic lupus erythematosus with pulmonary hypertension--normalization of pulmonary artery pressure by long-term administration of beraprost sodium]. Ubukata M; Motegi M; Sendo Y; Suzuki T Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1307-12. PubMed ID: 8583727 [TBL] [Abstract][Full Text] [Related]
2. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension]. Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment of systemic lupus erythematosus and pulmonary hypertension with intravenous prostaglandin I2 followed by its oral analogue. Ooiwa H; Miyazawa T; Yamanishi Y; Hiyama K; Ishioka S; Yamakido M Intern Med; 2000 Apr; 39(4):320-3. PubMed ID: 10801148 [TBL] [Abstract][Full Text] [Related]
5. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of pulmonary hypertension associated with systemic lupus erythematosus with prostaglandin I2 and prostaglandin E1. Ignaszewski AP; Percy JS; Humen DP J Rheumatol; 1993 Mar; 20(3):595-6. PubMed ID: 8478885 [No Abstract] [Full Text] [Related]
7. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children. Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838 [TBL] [Abstract][Full Text] [Related]
8. Use of prostacyclin and its analogues in the treatment of cardiovascular disease. Fink AN; Frishman WH; Azizad M; Agarwal Y Heart Dis; 1999; 1(1):29-40. PubMed ID: 11720602 [TBL] [Abstract][Full Text] [Related]
9. Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. Groen H; Bootsma H; Postma DS; Kallenberg CG J Rheumatol; 1993 Jun; 20(6):1055-7. PubMed ID: 8350313 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension. Tamura M; Kurumatani H; Matsushita T Prostaglandins Leukot Essent Fatty Acids; 2001 Mar; 64(3):197-202. PubMed ID: 11334556 [TBL] [Abstract][Full Text] [Related]
13. [Epoprostenol in the treatment of portopulmonary hypertension]. Culafić D; Culafić-Vojinović V; Jesić R Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137 [TBL] [Abstract][Full Text] [Related]
14. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation. Conte JV; Gaine SP; Orens JB; Harris T; Rubin LJ J Heart Lung Transplant; 1998 Jul; 17(7):679-85. PubMed ID: 9703232 [TBL] [Abstract][Full Text] [Related]
15. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension. Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327 [TBL] [Abstract][Full Text] [Related]
16. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension]. Nakayama T; Ishikita T; Matsuura H; Saji T J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726 [TBL] [Abstract][Full Text] [Related]
17. Perfusion lung scan as a prognostic indicator of response to beraprost sodium in idiopathic pulmonary arterial hypertension. Park SY; Moon DH; Park YB; Na JO; Whang HK; Lim BS; Lee SD Pulm Pharmacol Ther; 2006; 19(4):264-71. PubMed ID: 16139536 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics. Mahowald ML; Weir EK; Ridley DJ; Messner RP J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200 [TBL] [Abstract][Full Text] [Related]
19. Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension. Stricker H; Domenighetti G; Fiori G; Mombelli G Schweiz Med Wochenschr; 1999 Jun; 129(24):923-7. PubMed ID: 10413827 [TBL] [Abstract][Full Text] [Related]
20. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Robbins IM; Gaine SP; Schilz R; Tapson VF; Rubin LJ; Loyd JE Chest; 2000 Jan; 117(1):14-8. PubMed ID: 10631192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]